On the other hand, by binding to the CCR5 receptor, CCL5 can recruit immunosuppressive cells such as TAMs and inhibit the function of tumor-specific T cells, thereby exacerbating tumor immune escape (336, 379). The gene discussed is CCL5; the disease is neoplasm.